Trial reportSpine2026
Dual-Polymer Carboxymethyl Cellulose and Poly(Ethylene Oxide) Gel Reduces Leg and Back Pain in Patients With Severe Leg and Back Pain Following Single-Level Partial Discectomy.
Trial report in Spine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
STUDY
designProspective, randomized, double-blinded, multicenter trial.
objectiveEvaluate the safety and effectiveness of Oxiplex (dual-polymer gel) as an adjuvant during single-level partial discectomy in patients with severe leg and back pain. SUMMARY OF BACKGROUND DATA: Dual-polymer gel previously reduced leg and back pain after partial lumbar discectomy in a subgroup of patients with severe leg and back pain.
methodsFollowing single-level partial lumbar discectomy, participants were randomized to surgery plus dual-polymer gel (treatment) or surgery alone (control). The primary endpoint was the reduction in leg pain on the visual analog scale (VAS) at 6 months. Secondary outcomes were reductions in Sciatica Bothersomeness Index (SBI), back pain VAS, Oswestry Disability Index (ODI), SF-12 Mental (MCS) and Physical (PCS) Component Summaries, return to work, and patient satisfaction at 6-months.
resultsOne hundred thirty-four participants were randomized 2:1 [ITT cohort (N=134); n=87 Treatment; n=47 controls]. There were no clinical differences in safety or adverse events. Following removal of participants with protocol deviations, the Per Protocol cohort was N=102 (n=69 treatments; n=33 controls). Reductions in VAS leg pain, primary outcome measure, were not different (treatment -73.9; control -72.7). However, VAS Leg Pain improved by 100% for 33 of 68 treatments (5% increase vs. controls); ≥90% for 50 treatments (11% increase vs. controls). SBI decreased by 100% for 20 of 67 Treatments (11% increase vs. controls); SBI decreased by ≥90% for 33 treatments (24% increase vs. controls). SBI leg pain component decreased ≥80% in treatments vs. 66% of controls; P =0.039. More treatments achieved meaningful VAS back pain reduction (≥30%) than controls (93% vs. 88%). ODI decreased by 100% for 20 of 68 treats (13% increase vs. controls).
conclusionThe addition of dual-polymer gel as an adjuvant to partial discectomy for the treatment of severe pain, reduced leg and back pain, as well as increased the proportion of participants with the best responses to surgery. EVIDENCE OF LEVEL: Level I.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.